← Back to Search

IV Medications for Colorectal Cancer

Phase 3
Waitlist Available
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up postoperative day 0-2
Awards & highlights

Study Summary

This trial is examining the impact of adding magnesium to a preexisting surgical recovery protocol in place of preoperative oral medication. The goal is to improve outcomes including pain, total opioid consumption, and hospital length of stay.

Eligible Conditions
  • Colorectal Cancer
  • Anesthesia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~postoperative day 0-2
This trial's timeline: 3 weeks for screening, Varies for treatment, and postoperative day 0-2 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Recovery 40 Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Magnesium GroupExperimental Treatment1 Intervention
The magnesium group (Mg) will receive a bolus of 50 mg/kg of IV magnesium prior to incision and an infusion of 15 mg/kg/hr, with no preoperative oral pregabalin. All groups will receive preoperative oral acetaminophen, preoperative NSAIDs, subcutaneous heparin, intraoperative TAP block, intraoperative dexamethasone, ondansetron, transdermal scopolamine patch, and postoperative care as per the current ERAS protocol.
Group II: Control GroupPlacebo Group1 Intervention
The control group (Ct) will receive saline solution and no IV magnesium or oral pregabalin. All groups will receive preoperative oral acetaminophen, preoperative NSAIDs, subcutaneous heparin, intraoperative TAP block, intraoperative dexamethasone, ondansetron, transdermal scopolamine patch, and postoperative care as per the current ERAS protocol.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
IV Medications
2022
Completed Phase 3
~90

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor
445 Previous Clinical Trials
145,624 Total Patients Enrolled

Media Library

IV Medications Clinical Trial Eligibility Overview. Trial Name: NCT05021263 — Phase 3
Colorectal Cancer Research Study Groups: Control Group, Magnesium Group
Colorectal Cancer Clinical Trial 2023: IV Medications Highlights & Side Effects. Trial Name: NCT05021263 — Phase 3
IV Medications 2023 Treatment Timeline for Medical Study. Trial Name: NCT05021263 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the most popular reasons to get an IV medication?

"IV Medicationsis commonly used to treat fibromyalgia but it is also an effective intervention for other conditions like anxiety disorders, vitamin b12 deficiency, and spinal cord."

Answered by AI

How many human test subjects are included in this research project?

"That is correct, the study is still open and looking for 110 participants from a single site. The listing on clinicaltrials.gov has not been updated since June 3rd, 2022."

Answered by AI

Has the FDA greenlit intravenous treatments?

"IV medications have been studied enough that their safety can be estimated. In this case, our team rates them as a 3."

Answered by AI

Is this study presently looking for more participants?

"The clinical trial appears to be searching for patients, according to the data on clinicaltrials.gov. This trial was originally posted on 5/27/2022 and was most recently updated on 6/3/2022."

Answered by AI

Are the individuals in this clinical trial above the age of 18?

"The age limit to participate in this study is 75 years old, provided that the patient is above 18 years old."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
18 - 65
What site did they apply to?
Thomas Jefferson
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Does IV Magnesium Improve Quality of Recovery With ERAS Protocols in Laparoscopic Colorectal Surgery?
Kevin Min 2022. "Does IV Magnesium Improve Quality of Recovery With ERAS Protocols in Laparoscopic Colorectal Surgery?". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05021263.
~32 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top